Hydronephrosis Market Information: By Type (Unilateral, Bilateral), By Diagnosis (Laboratory Tests, Imaging), By Treatment (Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, Others), And By Indication (Intrinsic, Extrinsic) - Global Forecast Till 2027
The global hydronephrosis market is expected to show sharp growth over the forecast period. Increasing prevalence of kidney diseases and demand for diagnostics services in the field of nephrology are the key factor for the market growth. Rising geriatric population with chronic diseases affecting the kidney and increasing demand for advanced treatment measures also drive the market growth.
Get Sample Report at https://www.marketresearchfuture.com/sample_request/4223
The global Hydronephrosis Market Share is expected to grow at a CAGR of 10.2% during the forecast period and is estimated to reach USD 250 million by 2023.
Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “hydronephrosis market research report–Global forecast till 2023.”
Major Players in Hydronephrosis Market
Some of the Hydronephrosis Market Key Players in the global market are NephroGenex, Inc. (U.S), American Renal Associates (U.S), PHRAXIS, INC. (U.S), Renal Associates P.A. (U.S), ALLERGAN (U.S), Amgen Inc. (U.S), Anthem Bio Pharm (U.S), Sanofi (U.S), and Novartis AG (Germany)
The global hydronephrosis market is segmented on the basis of types, which includes unilateral and bilateral hydronephrosis.
On the basis of diagnosis, the market is segmented into laboratory test and imaging. Laboratory test is further sub-segmented into urinalysis, Complete Blood Count (CBC), electrolyte analysis, and others. Imaging is further sub-segmented into CT scan, ultrasound, intravenous pyelography, KUB X-rays, and others.
On the basis of treatment, the market is segmented into shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy, and others.
On the basis of indication, the market is segmented into intrinsic and extrinsic causes of hydronephrosis. Intrinsic causes are further sub-segmented into acute unilateral obstructive uropathy, kidney stone, bladder cancer, bladder stones, cystocele, urethral stricture, urethral cancer and others. Extrinsic causes are further sub-segmented into retroperitoneal fibrosis, ovarian vein syndrome, cancer of the cervix, cancer of the prostate, uterine prolapse, prostate cancer, and others.
The global hydronephrosis market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas dominates the global hydronephrosis market. It comprises of two regions namely North America and South America. North America is the largest market owing to extensive use of advanced diagnostics services and development of new drugs by leading market players for the treatment of hydronephrosis.
In the Europe, increasing adoption of new diagnostics techniques, increasing awareness about congenital anomalies, and overall development of healthcare sector contribute to the market growth.
Asia Pacific is the fastest growing and potential market for the hydronephrosis treatment, whose growth is attributed to the rising concerns over reproductive health of women and rising prevalence of hydronephrosis in the new born.
The Middle East & Africa is expected witness steady growth due to rising demand for primary healthcare services such as diagnosis and medical devices.
Report Details @ https://www.marketresearchfuture.com/reports/hydronephrosis-market-4223
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Phone: +1 646 845 9312
Email: [email protected]